(Q51483830)
Statements
Efficacy and tolerability of the dipeptidyl peptidase-4 inhibitor sitagliptin as monotherapy over 12 weeks in patients with type 2 diabetes. (English)
1 reference
Scott R
1 reference
Wu M
1 reference
Sanchez M
1 reference
Stein P
1 reference
5 December 2006
1 reference
61
1 reference
1
1 reference
171-180
1 reference